India’s Wholesale Registration Certificate: Form MD-41 and Form MD-42

1. Key takeaways

India’s wholesale registration certificate for medical devices is applied for on Form MD-41 and issued as Form MD-42, and the receiving authority is the State Licensing Authority (SLA). Where the documents are in order, the SLA may issue the certificate within 10 days from receipt of the application. The certificate is valid in perpetuity, but the holder must pay the registration certificate retention fee every 5 years as required under the Medical Devices Rules, 2017.

• Two forms, one route: application on MD-41, certificate issued as MD-42, filed through the online medical devices portal.
• 10 days is the statutory window: the SLA may issue the MD-42 within 10 days of receipt where the documents satisfy it.
• Validity is permanent, maintenance is not: the certificate never expires, but a retention fee falls due every 5 years.
• The SLA is state-bound: jurisdiction lies with the State Licensing Authority of the state where the applicant is located.

2. Legal basis

The framework for the wholesale registration route rests on the Medical Devices Rules, 2017, read together with the official CDSCO FAQ. The table below consolidates the operative points: who accepts the application, how fast the certificate can issue, how long it lasts, and what older pharmaceutical licences remain usable.

3. Expert insights

Insight 1: 10 days is one of the fastest administrative channels in Indian device regulation. Compared with the 9-month statutory period for an import licence and the 105–140 day periods for manufacturing licences, the wholesale registration certificate is almost immediate. This gives companies an important operational lever: obtain the MD-42 first, then pursue the import licence — and the MD-42 is itself a precondition for the MD-14 application. Sequencing the two filings in this order costs almost nothing in time and removes an eligibility blocker that would otherwise sit at the front of the import application. It also gives the agent candidate a concrete, verifiable credential early in the relationship, which makes the PoA negotiation easier to schedule.

Insight 2: valid in perpetuity does not mean maintenance-free. The retention fee every 5 years is a hard obligation. The consequences of missing it follow the retention-fee logic of the MDR 2017 (on the import licence side, the rule is: payment within 90 days of the due date attracts a late fee of 2% per month, and beyond that the licence is deemed to have been automatically cancelled — see Rule 37). Companies that treat the certificate as a one-time filing routinely discover the fee obligation only when a compliance review forces a look at the licence file. The practical estimate is simple: the certificate itself never lapses by passage of time, but the right to rely on it does depend on the fee cycle being kept current.

Insight 3: the certificate doubles as an agent-eligibility document. The MD-42 carries a triple identity — wholesale business qualification, import application eligibility, and authorised agent eligibility — which makes it the most widely used single certificate in the Indian device supply chain. One filing therefore serves the distributor’s own business, the manufacturer’s import application and the agent appointment simultaneously. When an agent candidate presents an MD-42, it should be read against all three roles at once: a certificate issued for distribution may be exactly the document the import filing needs, and the same document anchors the agent appointment.

Insight 4: operating across multiple states usually means considering multiple certificates. The SLA’s jurisdiction is state-based, so interstate operation requires separate filings or a confirmation of the applicable scope in each state. This is a direct consequence of India’s federal structure, and it should be built into the rollout plan rather than discovered state by state after shipments begin.

4. Practical recommendations

• Start the MD-42 process at the earliest stage of the India project. GRZAN advises clients to initiate the MD-42 in parallel with the PoA authentication chain, because the certificate is a precondition for everything that follows and takes only 10 days to obtain.
• File through the online medical devices portal with the fee per the Second Schedule. Confirm the fee line before submission so the application is not returned for an incorrect payment.
• Register the 5-year retention fee milestone in the compliance calendar. Many companies obtain a certificate in 10 working days and then forget it in year 5 — put the date in the calendar when the certificate is issued.
• Confirm SLA scope before interstate distribution. Where the business will cover several states, check each state’s requirement and confirm whether separate filings are needed.
• Check whether the candidate already holds Form 20B/21B/21C. A drug wholesale licence already applies to devices, so an existing pharmaceutical distributor may not need a fresh MD-42.

5. Verification checklist

• □ The MD-41 has been submitted through the online medical devices portal
• □ The receiving authority is the SLA of the state concerned
• □ The fee has been paid per the Second Schedule
• □ The 5-year retention fee milestone is recorded in the compliance calendar
• □ Interstate operation has been checked for separate state filings

Regulatory information verified as of 27 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including India. Our team prepares dossiers to CDSCO expectations, manages SUGAM submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com